𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Cardiovascular Effects of Peroxisome Proliferator-activated Receptor Agonists

✍ Scribed by Sayuri N. Friedland; Aaron Leong; Kristian B. Filion; Jacques Genest; Iliana C. Lega; Salvatore Mottillo; Paul Poirier; Jennifer Reoch; Mark J. Eisenberg


Book ID
116213247
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
317 KB
Volume
125
Category
Article
ISSN
1555-7162

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Peroxisome proliferator-activated recept
✍ Timothy M Willson; Walter Wahli πŸ“‚ Article πŸ“… 1997 πŸ› Elsevier Science 🌐 English βš– 848 KB

The peroxisome proliferator-activated receptors are a family of three ligand-activated transcription factors. Fibrate antihyperlipidemic drugs and thiazolidinedione antihyperglycemic drugs were recently identified as synthetic ligands for these receptors. In addition, certain unsaturated fatty acids

Effects of peroxisome proliferator-activ
✍ Tammy Kielian; Paul D. Drew πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 225 KB πŸ‘ 1 views

## Abstract Peroxisome proliferator‐activated receptor‐γ (PPAR‐γ) plays a critical role in glucose and lipid metabolism. More recently, PPAR‐γ ligands have been reported to inhibit the expression of proinflammatory molecules by monocytes/macrophages. Of relevance to CNS disease is that PPAR‐γ agoni